308 related articles for article (PubMed ID: 37751137)
21. Benzo[
Kim YJ; Lee DH; Choi YS; Jeong JH; Kwon SH
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31775247
[TBL] [Abstract][Full Text] [Related]
22. Development of JmjC-domain-containing histone demethylase (KDM2-7) inhibitors for cancer therapy.
Zhang L; Chen Y; Li Z; Lin C; Zhang T; Wang G
Drug Discov Today; 2023 May; 28(5):103519. PubMed ID: 36754142
[TBL] [Abstract][Full Text] [Related]
23. Kdm4b histone demethylase is a DNA damage response protein and confers a survival advantage following γ-irradiation.
Young LC; McDonald DW; Hendzel MJ
J Biol Chem; 2013 Jul; 288(29):21376-21388. PubMed ID: 23744078
[TBL] [Abstract][Full Text] [Related]
24. Characterization of a Linked Jumonji Domain of the KDM5/JARID1 Family of Histone H3 Lysine 4 Demethylases.
Horton JR; Engstrom A; Zoeller EL; Liu X; Shanks JR; Zhang X; Johns MA; Vertino PM; Fu H; Cheng X
J Biol Chem; 2016 Feb; 291(6):2631-46. PubMed ID: 26645689
[TBL] [Abstract][Full Text] [Related]
25. The KDM4/JMJD2 histone demethylases are required for hematopoietic stem cell maintenance.
Agger K; Nishimura K; Miyagi S; Messling JE; Rasmussen KD; Helin K
Blood; 2019 Oct; 134(14):1154-1158. PubMed ID: 31434704
[TBL] [Abstract][Full Text] [Related]
26. Heme promotes transcriptional and demethylase activities of Gis1, a member of the histone demethylase JMJD2/KDM4 family.
Lal S; Comer JM; Konduri PC; Shah A; Wang T; Lewis A; Shoffner G; Guo F; Zhang L
Nucleic Acids Res; 2018 Jan; 46(1):215-228. PubMed ID: 29126261
[TBL] [Abstract][Full Text] [Related]
27. A comprehensive review of lysine-specific demethylase 1 and its roles in cancer.
Hosseini A; Minucci S
Epigenomics; 2017 Aug; 9(8):1123-1142. PubMed ID: 28699367
[TBL] [Abstract][Full Text] [Related]
28. Structural analysis of human KDM5B guides histone demethylase inhibitor development.
Johansson C; Velupillai S; Tumber A; Szykowska A; Hookway ES; Nowak RP; Strain-Damerell C; Gileadi C; Philpott M; Burgess-Brown N; Wu N; Kopec J; Nuzzi A; Steuber H; Egner U; Badock V; Munro S; LaThangue NB; Westaway S; Brown J; Athanasou N; Prinjha R; Brennan PE; Oppermann U
Nat Chem Biol; 2016 Jul; 12(7):539-45. PubMed ID: 27214403
[TBL] [Abstract][Full Text] [Related]
29. KDM4B: A promising oncology therapeutic target.
Ni F; Tang H; Cheng S; Yu Y; Yuan Z; Chen Y; Zhang E; Wang X
Cancer Sci; 2024 Jan; 115(1):8-16. PubMed ID: 37923555
[TBL] [Abstract][Full Text] [Related]
30. Histone demethylase JMJD1A in cancer progression and therapeutic resistance.
Jeon HY; Ryu H; Pornour M; Qi J
Mol Carcinog; 2022 Apr; 61(4):392-396. PubMed ID: 35020958
[TBL] [Abstract][Full Text] [Related]
31. Heat shock protein 90 (Hsp90) selectively regulates the stability of KDM4B/JMJD2B histone demethylase.
Ipenberg I; Guttmann-Raviv N; Khoury HP; Kupershmit I; Ayoub N
J Biol Chem; 2013 May; 288(21):14681-7. PubMed ID: 23589305
[TBL] [Abstract][Full Text] [Related]
32. Inhibitors of Jumonji C domain-containing histone lysine demethylases overcome cisplatin and paclitaxel resistance in non-small cell lung cancer through APC/Cdh1-dependent degradation of CtIP and PAF15.
Duan L; Perez RE; Calhoun S; Maki CG
Cancer Biol Ther; 2022 Dec; 23(1):65-75. PubMed ID: 35100078
[TBL] [Abstract][Full Text] [Related]
33. Genome-wide Kdm4 histone demethylase transcriptional regulation in Drosophila.
Tsurumi A; Xue S; Zhang L; Li J; Li WX
Mol Genet Genomics; 2019 Oct; 294(5):1107-1121. PubMed ID: 31020413
[TBL] [Abstract][Full Text] [Related]
34. C8-substituted pyrido[3,4-d]pyrimidin-4(3H)-ones: Studies towards the identification of potent, cell penetrant Jumonji C domain containing histone lysine demethylase 4 subfamily (KDM4) inhibitors, compound profiling in cell-based target engagement assays.
Le Bihan YV; Lanigan RM; Atrash B; McLaughlin MG; Velupillai S; Malcolm AG; England KS; Ruda GF; Mok NY; Tumber A; Tomlin K; Saville H; Shehu E; McAndrew C; Carmichael L; Bennett JM; Jeganathan F; Eve P; Donovan A; Hayes A; Wood F; Raynaud FI; Fedorov O; Brennan PE; Burke R; van Montfort RLM; Rossanese OW; Blagg J; Bavetsias V
Eur J Med Chem; 2019 Sep; 177():316-337. PubMed ID: 31158747
[TBL] [Abstract][Full Text] [Related]
35. Structure-Based Screening of Tetrazolylhydrazide Inhibitors versus KDM4 Histone Demethylases.
Małecki PH; Rüger N; Roatsch M; Krylova O; Link A; Jung M; Heinemann U; Weiss MS
ChemMedChem; 2019 Nov; 14(21):1828-1839. PubMed ID: 31475772
[TBL] [Abstract][Full Text] [Related]
36. Histone demethylase JMJD2B/KDM4B regulates transcriptional program via distinctive epigenetic targets and protein interactors for the maintenance of trophoblast stem cells.
Mak KH; Lam YM; Ng RK
Sci Rep; 2021 Jan; 11(1):884. PubMed ID: 33441614
[TBL] [Abstract][Full Text] [Related]
37. Substrate- and cofactor-independent inhibition of histone demethylase KDM4C.
Leurs U; Lohse B; Rand KD; Ming S; Riise ES; Cole PA; Kristensen JL; Clausen RP
ACS Chem Biol; 2014 Sep; 9(9):2131-8. PubMed ID: 25014588
[TBL] [Abstract][Full Text] [Related]
38. Quantitative high-throughput screening identifies 8-hydroxyquinolines as cell-active histone demethylase inhibitors.
King ON; Li XS; Sakurai M; Kawamura A; Rose NR; Ng SS; Quinn AM; Rai G; Mott BT; Beswick P; Klose RJ; Oppermann U; Jadhav A; Heightman TD; Maloney DJ; Schofield CJ; Simeonov A
PLoS One; 2010 Nov; 5(11):e15535. PubMed ID: 21124847
[TBL] [Abstract][Full Text] [Related]
39. Histone demethylase lysine demethylase 5B in development and cancer.
Han M; Xu W; Cheng P; Jin H; Wang X
Oncotarget; 2017 Jan; 8(5):8980-8991. PubMed ID: 27974677
[TBL] [Abstract][Full Text] [Related]
40. Structure of the Arabidopsis JMJ14-H3K4me3 Complex Provides Insight into the Substrate Specificity of KDM5 Subfamily Histone Demethylases.
Yang Z; Qiu Q; Chen W; Jia B; Chen X; Hu H; He K; Deng X; Li S; Tao WA; Cao X; Du J
Plant Cell; 2018 Jan; 30(1):167-177. PubMed ID: 29233856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
